These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7636788)

  • 1. New treatment for porphyria to be studied.
    J Psychosoc Nurs Ment Health Serv; 1995 May; 33(5):46. PubMed ID: 7636788
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute attacks of hepatic porphyria: specific treatment with heme arginate].
    Nordmann Y; Deybach JC
    Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of haem arginate on variegate porphyria.
    Timonen K; Mustajoki P; Tenhunen R; Lauharanta J
    Br J Dermatol; 1990 Sep; 123(3):381-7. PubMed ID: 2206975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three cases of acute porphyria-experience with heme therapy in one case.
    Bhootra K; Bhootra RK
    J Assoc Physicians India; 1995 Apr; 43(4):303-4. PubMed ID: 8713283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute intermittent porphyria. The first use of Heme-arginate in Czechoslovakia].
    Kordac V; Martásek P
    Cas Lek Cesk; 1987 Jul; 126(30):944-7. PubMed ID: 3652151
    [No Abstract]   [Full Text] [Related]  

  • 6. Heme arginate (Normosang) in the treatment of attacks of acute hepatic porphyrias.
    Kostrzewska E; Gregor A; Tarczyńska-Nosal S
    Mater Med Pol; 1991; 23(4):259-62. PubMed ID: 1842231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological complications of acute intermittent porphyria precipitated by porphyrinogenic drugs and efficiency of heme-arginate treatment].
    Akopova-Larbi R; Ben Youssef TI; Gargouri A; Kraoua I; Gouider R; Gouider-Khouja N
    Tunis Med; 2009 Sep; 87(9):621-6. PubMed ID: 20180386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new drug for porphyria].
    Tenhunen R
    Nord Med; 1986; 101(4):132-3. PubMed ID: 3737395
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlled trial of haem arginate in acute hepatic porphyria.
    Herrick AL; McColl KE; Moore MR; Cook A; Goldberg A
    Lancet; 1989 Jun; 1(8650):1295-7. PubMed ID: 2566827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical manifestations and diagnosis of acute porphyria].
    Pustovoĭt IaS; Pivnik AV; Karpova IV
    Ter Arkh; 1999; 71(7):76-80. PubMed ID: 10481873
    [No Abstract]   [Full Text] [Related]  

  • 11. Early administration of heme arginate for acute porphyric attacks.
    Mustajoki P; Nordmann Y
    Arch Intern Med; 1993 Sep; 153(17):2004-8. PubMed ID: 8357285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute porphyrias. The importance of follow-up of patients and carriers].
    Tasnádi G; Bor M; Pusztai A
    Orv Hetil; 2003 May; 144(19):933-8. PubMed ID: 12809070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of a new hematin in the treatment of an acute attack of porphyria].
    Fontaine B; Bakchine S; Derouesne C; Nordmann Y; Laplane D
    Presse Med; 1987 Feb; 16(4):177. PubMed ID: 2950457
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of porphyria.
    Cardinal RA; Pierach CA
    J Clin Psychiatry; 1981 Jul; 42(7):291. PubMed ID: 7240116
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochrome C in the treatment of porphyria.
    Lang PA; Levine H; Jones CC; Mills GC
    Tex Rep Biol Med; 1968; 26(4):525-34. PubMed ID: 5718717
    [No Abstract]   [Full Text] [Related]  

  • 16. Haem and porphyria attacks.
    Pierach CA
    Lancet; 1989 Jul; 2(8656):213-4. PubMed ID: 2568536
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma porphobilinogen as a sensitive biomarker to monitor the clinical and therapeutic course of acute intermittent porphyria attacks.
    Sardh E; Harper P; Andersson DE; Floderus Y
    Eur J Intern Med; 2009 Mar; 20(2):201-7. PubMed ID: 19327613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical manifestations of porphyrin metabolism disorders].
    Pustovoĭt IaS; Karpova IV; Pivnik AV; Surin VL; Luk'ianenko AV; Luchinina IuA
    Ter Arkh; 2003; 75(7):68-73. PubMed ID: 12934485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory collapse associated with hemin therapy for acute intermittent porphyria.
    Khanderia U
    Clin Pharm; 1986 Aug; 5(8):690-2. PubMed ID: 3742954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differential approaches to intensive care of patients with severe acute porphyria].
    Pustovoĭt IaS; Iatskov KV; Karpova IV; Shulutko EM
    Anesteziol Reanimatol; 2009; (2):39-45. PubMed ID: 19517614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.